research Early-Onset Effluvium Secondary to COVID-19: Clinical and Histologic Characterization
COVID-19 can cause hair loss starting as early as 18 days after infection.
Search
for
Sort by
Research
690-720 / 1000+ results 
research Race, Ethnicity, and Comorbidities Are Critical Factors in the Diagnosis of Telogen Effluvium During the COVID-19 Pandemic
Hair loss (telogen effluvium) cases rose during the pandemic, especially in Hispanic and non-White groups, and were linked to other health issues and COVID-19.
research Dermatological Manifestations of COVID-19 in Children
COVID-19 can cause skin problems in children.
research New Insights into Alopecia Areata During COVID-19 Pandemic: When Infection or Vaccination Could Play a Role
COVID-19 infection or vaccination may influence the development of alopecia areata, a type of hair loss.
research COVID-19: A Catalyst for Innovative Hybrid Teledermatology Workflows to Increase Access and Improve Patient Care at a Large Group Practice
A new teledermatology system improved access and reduced wait times for skin care.
research Androgenetic Alopecia in COVID-19: Compared to What?
Hair loss link to severe COVID-19 unclear.
research Association Between Hair Diseases and COVID-19 Pandemic-Related Stress: A Cross-Sectional Study Analysis
The study suggests pandemic stress might worsen or trigger hair loss problems.
research COVID-19 Lockdown And Beyond: Home Practice Solutions For Developing Microsurgical Skills
Home practice solutions using simple materials can help maintain microsurgical skills during lockdowns.
research Hair and Nail Manifestations of COVID-19
COVID-19 can cause hair loss and nail changes in some patients.
research The Role of Autologous Micrografts Injection from Scalp Tissue in the Treatment of COVID-19 Associated Telogen Effluvium: Clinical and Trichoscopic Evaluation
Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.
research Cepharanthine: A Review of the Antiviral Potential of a Japanese-Approved Alopecia Drug in COVID-19
Cepharanthine could be a strong antiviral against COVID-19.
research Impact of Anti-Androgen Therapies on COVID-19 Susceptibility: A Case-Control Study in Male Population from Two COVID-19 Regional Centers of Lombardy, Italy
Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.
research Diagnosis of Stress-Associated Dermatologic Conditions in New York City Safety-Net Hospitals During the COVID-19 Pandemic
During the COVID-19 pandemic, more people were diagnosed with stress-related skin conditions like acne and temporary hair loss.
research Indirect Skin Sign of COVID-19 Days: Striae Rubrae
The COVID-19 pandemic led to more young people getting red stretch marks due to lifestyle changes like less activity and quick weight gain.
research Covid-19 Patients at Referral to Hospital During the First Peak of Disease: Common Clinical Findings Including Myalgia and Fatigue
Most hospitalized COVID-19 patients experienced shortness of breath, dry cough, fever, muscle pain, and fatigue.
research Telogen Effluvium Caused by COVID-19 in Elmhurst, New York: Report of a Cohort and Review
COVID-19 has increased hair loss, but many patients see regrowth within months.
research A Response to 'Male Balding Is a Major Risk Factor for Severe COVID-19'
The authors suggest that scalp hair might protect against COVID-19 and call for more research on scalp health and the virus.
research Development of Pilomatrixoma at the Vaccination Site: A Rare Complication of COVID-19 Vaccination – A Case Report
A man developed a benign tumor at his COVID-19 vaccination site, which was successfully removed with surgery.
research COVID-19 Pandemic and Teledermatology in Low-Income Regions
The COVID-19 pandemic increased the use of teledermatology to treat skin conditions in low-income areas, despite challenges like poor photo quality.
research COVID-19 Dermatological Manifestations: Results from the Mexican Academy of Dermatology COVID-19 Registry
COVID-19 can cause skin issues like hives, rashes, and chickenpox-like eruptions, with women aged 31-40 being the most affected.
research Global Impact of Coronavirus Disease 2019 (COVID-19)
COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.
research Platelet-Rich Plasma Treatment for Accelerated Androgenetic Alopecia Pattern Hair Loss After COVID-19 Infection: A Case Series
PRP treatment effectively reduces hair loss after COVID-19.
research Reply to Letter to the Editor: A Response to 'Male Balding Is a Major Risk Factor for Severe COVID-19'
Balding might help identify men at higher risk for severe COVID-19, but more research is needed.
research Alopecia Universalis After Injection of Messenger RNA COVID-19 Vaccine: A Case Report
A patient experienced severe hair loss after getting an mRNA COVID-19 vaccine.
research Drug-Induced Lupus or Systemic Lupus Erythematosus After Experimental COVID-19 Therapy: Difficulties in Differential Diagnosis
Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.
research Rational Evaluation of Patients with COVID-19-Related Hair Loss
COVID-19 can cause different types of hair loss, and proper diagnosis by a specialist may be needed.
research Impact of COVID-19 on Asthmatic Patients in the Western Region of Saudi Arabia
Covid-19 affected asthmatic patients in Western Saudi Arabia.
research Cutaneous Manifestations of COVID-19
COVID-19 can cause various skin symptoms, including rashes and lesions, which often appear early and can help in timely diagnosis.
research Clinical Manifestations of COVID-19 on the Skin
COVID-19 can cause various skin issues, helping doctors diagnose it early.
research Correlation of COVID-19 and Hairfall: A Cross-Sectional Study
COVID-19 is linked to temporary hair loss, especially in women.